In February 2020, the thirteenth international Rare Disease Day was held, where hundreds of patient organisations from countries and regions all over the world organised rare disease awareness-raising activities. Aman Khera at Worldwide Clinical Trials delves into how the FDA continued their long-standing dialogue with the rare disease community, by holding their Rare Disease Day 2020 public meeting aimed at “Supporting the Future of Rare Disease Product Development”.